Study On TCM Treatment Of Chronic Renal Failure Ⅱ

2 Results
2.1 Comparison of clinical treatment effect between two groups of patients The total clinical
The total effective rate of treatment was 86.67% (26/30), which was significantly higher than that of the control group [70.00% (21/30)] (χ2=15.482, P＜0.05). See Table 2. table 2 Comparison of clinical treatment effects between two groups of patients [n (%)

2.2 Comparison of renal function indexes between two groups of patients
The endogenous creatinine clearance rates were (41.12 ± 5.84) mL/min and (46.72 ± 5.32) mL/min, and blood creatinine was (210.82 ± 17.64) μmol/L and (195.46 ± 19.59) μmol/L before and after treatment in the observation group, respectively.
The endogenous creatinine clearance rate was higher and blood creatinine was lower in the observation group than before treatment (t=7.834, 13.560, P<0.05). The endogenous creatinine clearance rate was (41.18 ± 5.93) mL/min, (43.51 ± 5.64) mL/min, and blood creatinine was (211.10 ± 18.30) μ mol/L, (202.71 ± 18.94) μ mol/L, and (211.10 ± 18.30) μ mol/L, respectively, before and after treatment in the control group with chronic renal failure.
(202.71 ± 18.94) μmol/L, and endogenous creatinine after treatment in the control group The clearance of endogenous creatinine in the control group was higher than that before treatment, and the blood creatinine was lower than that before treatment (t=5.127, 10.841, P<0.05). (t=5.127, 10.841, P<0.05); in the observation group, the endogenous creatinine clearance rate was higher than that before treatment and the blood creatinine was lower than that before treatment. The endogenous creatinine clearance rate was higher than that of the control group and the blood creatinine was lower than that of the control group (t=6.439, 10.841, P<0.05). (t=6.439, 9.725, P＜0.05).

Click Here to Know TCM  Cistanche FOR IMPROVE the KIDNEY FUNCTION

ASK MORE:

wallence.suen@wecistanche.com 0015292862950

2.3 Comparison of serum related indexes between the two groups
The serum β2 microglobulin was (8.62±2.47) μg/m before and after treatment in patients with chronic renal failure, respectively. (2.47) μg/mL, (7.19±1.43) μg/mL, cystatin C (4.79±1.56) mg/L and (3.68±0.84) mg/L, respectively. After treatment, the serum β2 microglobulin and cystatin C serum related indexes were lower than those before treatment. were lower than those before treatment, and the differences were statistically significant (t=6.732, 6.420, and P < 0.05); in the control group, serum β2 microglobulin and cystatin C serum-related indexes were lower before and after treatment in patients with chronic renal failure. In the control group, serum β2 microglobulin was (8.63±2.45) μg/mL, (7.70±1.89) μg/mL before and after treatment, respectively. 1.89) μg/mL and cystatin C were (4.83±1.59) mg/L and (4.46±1.23) mg/L, respectively.
(4.46±1.23) mg/L, serum β2 microglobulin and cystatin C serum related indexes were lower in the control group after treatment than before treatment, and the difference was statistically significant (t=5.127, 4.269, P<0.05); serum β2 microglobulin and cystatin C serum related indexes were lower in the observation group with chronic renal failure than in the control group after treatment, and the difference was statistically significant (t= 4.835, 5.257, P < 0.05).5.257, P < 0.05).

2.4 Comparison of clinical symptom scores between the two groups The observation group of patients with chronic renal
Before and after treatment, the scores of patients with chronic renal failure in the observation group were (2.41±0.82) and (0.32±0.07) for back and knee weakness, (2.52±0.73) and (0.26±0.10) for tiredness, and (2.60±0.66) and (0.37±0.05) for lack of food and numbness, respectively. In the observation group, the clinical symptom scores of chronic renal failure patients were lower than those before treatment, and the differences were statistically significant (t=5.632, 5.584, 5.971, P<0.05); in the control group, the scores of chronic renal failure patients before and after treatment were (2.36±0.74) and (0.68±0.26) for back and knee weakness, (2.53±0.79) and (0.74±0.35) for tiredness and fatigue, respectively. (0.74±0.35), and the scores of food and fatigue were (2.53±0.79) and (0.74±0.35), respectively. (2.57±0.63), (0.70±0.22), and (2.57±0.63), respectively. In the control group, patients with chronic renal failure had lower clinical symptom scores than the control group after treatment, including weakness of the waist and knees, tiredness and fatigue, and The clinical symptom scores of chronic renal failure patients in the control group were lower than those before treatment, and the difference was statistically significant (t=4.8). The difference was statistically significant (t=4.873, 4.932, 4.753, P<0.05); in the observation group The clinical symptom scores of chronic renal failure patients were lower than those of the control group after treatment.
The clinical symptom scores of nadir were lower than those of the control group, and the differences were statistically significant (t=4.158, 4.202, 4.138, P＜0.05).

2.5 Comparison of Chinese medicine evidence points between two groups of patients
The TCM evidence points of patients with chronic renal failure in the observation group were (18.70±2.94) and (9.42±1.55) before and after treatment, respectively, and those of patients with chronic renal failure in the control group were (18.53±2.85) and (15.79±2.18) before and after treatment, respectively. The TCM evidence points of chronic renal failure patients after treatment were lower than those before treatment, and those of chronic renal failure patients in the observation group were lower than those in the control group after treatment, and the differences were statistically significant (t=10.340, 5.881, 7.953, P<0.05).

2.6 Comparison of patient satisfaction in the two groups
The total satisfaction of patients in the observation group degree was 93.33% (28/30), which was significantly higher than that of the control group [66.67%(20/30)] (χ 2 = 27.431, P < 0.05). See Table 3.

2.7 Comparison of adverse reactions between the two groups The total incidence of adverse reactions in the observation patients was 0.00%. The total incidence of adverse reactions in the observation patients was 0.00%, and the total incidence of adverse reactions in the control group was 23.33%. 23.33%, the difference was statistically significant. (χ 2 The difference was statistically significant (χ 2 = 27.431, P < 0.05). See Table 4.
Table 4

3 DISCUSSION
In this paper, we take chronic renal failure as an example and use Western medical treatment and Chinese Chinese medicine treatment methods, to compare whether the application of Chinese medicine treatment methods can improve the indexes of renal function of patients. patients' adverse reactions, to determine whether TCM treatments The study was conducted from the perspective of safety. In this study, from the perspective of treatment safety The present study selected TCM treatment for chronic renal failure patients from the perspective of therapeutic safety. The clinical indexes of patients treated with Western medicine and Chinese medicine were compared. The results showed that Chinese medicine was the most effective treatment for chronic renal failure. The results showed that the effect of TCM treatment method was significant. The results showed that the effect of TCM treatment was significant, and it is clear that this study has positive significance, and TCM treatment has a significant effect in patients with chronic renal failure.

The results showed that the effect of TCM treatment was significant, and the study has positive significance, and TCM treatment has significant advantages in patients with chronic renal failure. However, there are data in the literature on the effects of combined Chinese and Western medicine on chronic renal failure patients. However, some literature has used a combination of Western and Chinese medicine to treat patients with chronic renal failure in a single, combined The clinical indexes, therapeutic effects and adverse effects of chronic renal failure patients treated with Western medicine alone, in combination with Chinese medicine or and adverse reactions in patients with chronic renal failure under single, combined Western medicine or Chinese medicine treatment, and the clinical opinion is more significant compared with this paper. Therefore, there are some shortcomings in this study.

The results of this study showed that after treatment, the endogenous creatinine clearance, blood creatinine, serum β2 microglobulin, and cystatin C were all better than those of the control group. The results of this study showed that the endogenous creatinine clearance rate, blood creatinine, serum β2 microglobulin and cystatin C in the observation group were better than those in the control group. The patients' endogenous creatinine clearance rate, blood creatinine, serum β2 microglobulin and cystatin C were better than those of the control group. After treatment, the patients with chronic renal failure in the observation group After treatment, the scores of weakness of the waist and knees, tiredness and fatigue, low food intake and dullness, and
The Chinese medicine symptoms score was better than that of the control group, which showed that the Chinese medicine treatment method could significantly improve the clinical symptoms of patients. significantly improve the clinical symptoms of the patients, and the improvement of clinical symptoms indicates that the patients' treatment The improvement of clinical symptoms indicated that the patients' efficacy was improved, and it has positive significance for improving the symptoms of TCM in patients with chronic renal failure. The improvement of clinical symptoms indicated that the efficacy of patients' treatment was improved, and it had positive significance for improving the symptoms of TCM in patients with chronic renal failure. The total satisfaction rate of patients in the observation group was 93.33%, which was higher than that of the control group. It can be seen that patients with chronic renal failure are more satisfied with TCM treatment methods. The percentage of very satisfied patients with chronic renal failure under TCM treatment method was more than 50%. The percentage of very satisfied patients with chronic renal failure under TCM treatment was more than 50%, while the percentage of very satisfied patients with chronic renal failure under Western medicine treatment was less than 50%. This shows that the recognition of TCM treatment methods is higher.

Observed patients No adverse effects of elevated blood pressure, hyperkalemia, cardiovascular and cerebrovascular diseases were observed. This indicates that the safety of TCM treatment methods is high, while the safety of Western medicine treatment methods is high. The patients with chronic renal failure under the western medicine treatment method had elevated blood pressure, hyperkalemia, cardiovascular and cerebrovascular The total incidence of adverse reactions such as elevated blood pressure, hyperkalemia, and cardiovascular disease in patients with chronic renal failure under Western medicine treatment was 23.33%, indicating that the safety of Western medicine treatment was high. The total incidence rate was 23.33%, indicating that the safety of Western medical treatment was inferior to that of TCM treatment. It can be seen that TCM treatment methods can significantly improve the safety of treatment for patients with chronic renal failure. The safety of the treatment of chronic renal failure patients was significantly improved by Chinese medicine. If patients with chronic renal failure develop blood pressure elevated blood pressure, hyperkalemia, cardiovascular disease, etc. during the treatment of chronic renal failure patients, it will be harmful to the patient's body and may lead to patients with chronic renal failure, which may lead to life-threatening conditions. Therefore, under TCM treatment, the concept of treating the disease can be applied to prevent the adverse effects. Therefore, under TCM treatment, we can apply the concept of treating the disease to prevent the adverse effects effectively, and adjust the drug combination to Therefore, under TCM treatment, the concept of treating the disease can be applied to effectively prevent all adverse reactions, and by adjusting the drug combination, the common adverse reactions can be prevented.
In conclusion, the clinical efficacy of TCM treatment in patients with chronic renal failure is significantly better than that of Western medicine. The clinical efficacy of TCM treatment in patients with chronic renal failure is significantly better than that of Western medicine, and TCM treatment methods can significantly Chinese medicine treatment can significantly improve renal function indexes, serum-related indexes, clinical symptoms and reduce Chinese medicine treatment methods can significantly improve patients' renal function indexes, serum-related indexes, clinical symptoms, reduce their TCM syndrome scores, improve patient satisfaction, and improve treatment safety. The clinical efficacy of TCM treatment was significantly better than that of Western medicine.